Skip to main content
Top
Published in: BMC International Health and Human Rights 1/2010

Open Access 01-12-2010 | Research

Can incubators work in Africa? Acorn Technologies and the entrepreneur-centric model

Authors: Justin Chakma, Hassan Masum, Peter A Singer

Published in: BMC International Health and Human Rights | Special Issue 1/2010

Login to get access

Abstract

Background

Incubators are organizations that support the growth of new and typically technology-based enterprises, by providing business support services that bring together human and financial capital. Although the traditional role of incubators has been for economic development, they may also be a useful policy lever to tackle global health, by fostering the development and delivery of local health innovation.
Given its high disease burden, life sciences incubators hold particular potential for Africa. As the most industrially advanced African nation, South Africa serves as a litmus test for identifying effective incubator policies. The case study method was used to illustrate how one such publicly funded incubator founded in 2002, Acorn Technologies, helped to catalyze local health product innovation.

Discussion

Acorn helped to support twelve biomedical device firms. One of them, Real World Diagnostics, was founded by a trainee from Acorn’s innovative internship program (Hellfire). It developed rapid strip diagnostic tests for locally prevalent diseases including schistosomiasis and HIV, and reported $2 million (USD) in revenue in 2009.
Acorn achieved this success by operating as a non-profit virtual incubator with little physical infrastructure. Employing a virtual model in combination with stringent selection criteria of capital efficiency for clients proved to be effective in reducing its own fixed costs. Acorn focused on entrepreneurship training and networking, both critical at an early stage in an environment dominated by multinational biomedical device companies.
Acorn and its clients learned that employing a cross-subsidy business model allowed one to generate royalty revenue through imports to subsidize R&D for local diseases. However, funding constraints and government expectations for rapid self-sustainability forced Acorn to merge with its sister biotechnology incubator in 2009.

Summary

A key to Acorn’s achievements was identifying entrepreneurs with technologies with health and economic impact, and providing them with flexible support from an early stage. A virtual organizational model helped Acorn to focus on supporting entrepreneurs. Governments and funders may wish to consider incubation strategies that draw from these good practices. With the right policies and business models, incubators have the potential to generate both health and economic benefits for Africa.
Literature
1.
go back to reference Scaramuzzi E: Incubators in Developing Countries: Status and Development Perspectives. 2002, Washington DC: The World Bank Scaramuzzi E: Incubators in Developing Countries: Status and Development Perspectives. 2002, Washington DC: The World Bank
2.
go back to reference Masum H, Daar AS, Al-Bader S, Shah R, Singer PA: Accelerating Health Product Innovation in sub-Saharan Africa. MIT Innovations. 2007, 2: 129-149.CrossRef Masum H, Daar AS, Al-Bader S, Shah R, Singer PA: Accelerating Health Product Innovation in sub-Saharan Africa. MIT Innovations. 2007, 2: 129-149.CrossRef
3.
go back to reference Singer PA, Berndtson K, Shawn Tracy C, Cohen ERM, Masum H, Daar AS: A Tough Transition. Nature. 2007, 449 (7159): 160-163. 10.1038/449160a.CrossRefPubMed Singer PA, Berndtson K, Shawn Tracy C, Cohen ERM, Masum H, Daar AS: A Tough Transition. Nature. 2007, 449 (7159): 160-163. 10.1038/449160a.CrossRefPubMed
4.
go back to reference International Finance Corporation: The Business of Health in Africa. 2007, Washington D.C.: The World Bank Group International Finance Corporation: The Business of Health in Africa. 2007, Washington D.C.: The World Bank Group
5.
go back to reference Al-Bader S, Frew SE, Essajee I, Liu VY, Daar AS, Singer PA: Small but tenacious: South Africa’s health biotech sector. Nature Biotechnology. 2009, 27 (5): 427-445. 10.1038/nbt0509-427.CrossRefPubMed Al-Bader S, Frew SE, Essajee I, Liu VY, Daar AS, Singer PA: Small but tenacious: South Africa’s health biotech sector. Nature Biotechnology. 2009, 27 (5): 427-445. 10.1038/nbt0509-427.CrossRefPubMed
6.
go back to reference Hardy BJ, Seguin B, Ramesar R, Singer PA, Daar AS: South Africa: from species cradle to genomic applications. Nature Reviews Genetics. 2008, 9 (Suppl.): S19-23. 10.1038/nrg2441.CrossRefPubMed Hardy BJ, Seguin B, Ramesar R, Singer PA, Daar AS: South Africa: from species cradle to genomic applications. Nature Reviews Genetics. 2008, 9 (Suppl.): S19-23. 10.1038/nrg2441.CrossRefPubMed
10.
go back to reference Wojcik MH, Hawthorne JS: Sensitivity of commercial ethyl glucuronide (ETG) testing in screening for alcohol abstinence. Alcohol and Alcoholism. 2007, 42 (4): 317-320. 10.1093/alcalc/agm014.CrossRefPubMed Wojcik MH, Hawthorne JS: Sensitivity of commercial ethyl glucuronide (ETG) testing in screening for alcohol abstinence. Alcohol and Alcoholism. 2007, 42 (4): 317-320. 10.1093/alcalc/agm014.CrossRefPubMed
14.
go back to reference Frenkel A, Shefer D, Miller M: Public versus Private Technological Incubator Programmes: Privatizing the Technological Incubators in Israel. European Planning Studies. 2008, 16 (2): 189-210. 10.1080/09654310701814504.CrossRef Frenkel A, Shefer D, Miller M: Public versus Private Technological Incubator Programmes: Privatizing the Technological Incubators in Israel. European Planning Studies. 2008, 16 (2): 189-210. 10.1080/09654310701814504.CrossRef
15.
go back to reference United Nations Development Programme: Unleashing Entrepreneurship: Making Business Work for the Poor. 2004, New York: United Nations United Nations Development Programme: Unleashing Entrepreneurship: Making Business Work for the Poor. 2004, New York: United Nations
16.
go back to reference Frew SE, Rezaie R, Sammut SM, Ray M, Daar AS, Singer PA: India’s health biotech sector at a crossroads. Nature Biotechnology. 2007, 25: 403-417. 10.1038/nbt0407-403.CrossRefPubMed Frew SE, Rezaie R, Sammut SM, Ray M, Daar AS, Singer PA: India’s health biotech sector at a crossroads. Nature Biotechnology. 2007, 25: 403-417. 10.1038/nbt0407-403.CrossRefPubMed
18.
go back to reference Juma C, Serageldin I: Freedom to Innovate: Biotechnology in Africa’s Development: Report of the High-Level African Panel on Modern Biotechnology. 2007, Johannesburg, South Africa: African Union and New Partnership for Africa’s Development Juma C, Serageldin I: Freedom to Innovate: Biotechnology in Africa’s Development: Report of the High-Level African Panel on Modern Biotechnology. 2007, Johannesburg, South Africa: African Union and New Partnership for Africa’s Development
Metadata
Title
Can incubators work in Africa? Acorn Technologies and the entrepreneur-centric model
Authors
Justin Chakma
Hassan Masum
Peter A Singer
Publication date
01-12-2010
Publisher
BioMed Central
DOI
https://doi.org/10.1186/1472-698X-10-S1-S7

Other articles of this Special Issue 1/2010

BMC International Health and Human Rights 1/2010 Go to the issue